Tilray Inc., the cannabis company that has seen its valuation double, could become a US$100 billion company, according to its CEO Brendan Kennedy, as the regulations surrounding marijuana continue to ease across the globe. Tilray is interested in the burgeoning market for consumer products that use ingredients from marijuana, Kennedy said. “We’ve had lots of conversations with lots of companies,” though he declined to provide specific details. His comments come in the wake of high-profile cannabis industry investments by Constellation Brands Inc. in Canopy Growth Corp.. (See also: Tilray first Canadian company to import medical cannabis to U.S.| Weed stocks like Tilray are soaring — but could it be the new Bitcoin bubble?)